MARSHALL WACE, LLP - EFFECTOR THERAPEUTICS INC ownership

EFFECTOR THERAPEUTICS INC's ticker is and the CUSIP is 28202V116. A total of 23 filers reported holding EFFECTOR THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of EFFECTOR THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$67,000
-51.4%
16,6610.0%0.00%
Q4 2021$138,000
-41.0%
16,6610.0%0.00%
-100.0%
Q3 2021$234,00016,6610.00%
Other shareholders
EFFECTOR THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
MMCAP International Inc. SPC 145,941$18,8560.00%
ARISTEIA CAPITAL, L.L.C. 1,540,297$153,1060.00%
Sea Otter Advisors LLC 25,000$3,2300.00%
LITTLEJOHN & CO LLC 16,666$2,1530.00%
WHITEBOX ADVISORS LLC 298,145$38,5200.00%
Citadel Advisors 27,743$3,5840.00%
III Capital Management 41,795$4,1540.00%
Tower Research Capital LLC (TRC) 23$00.00%
Parallel Advisors, LLC 64,166$4,8120.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of EFFECTOR THERAPEUTICS INC shareholders